14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 20 May 2024

Trading levels for ALACT.PA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.13 17.36 %
R2 1.07 11.79 %
R1 1.04 8.35 %
Current price: 0.96
Support S1 0.93 -2.79 %
S2 0.90 -6.23 %
S3 0.85 -11.81 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 1.14 18.75 %
R1 0.98 2.29 %
Current price 0.96
Support S1 0.84 -12.50%
S2 0.80 -16.46%
S3 0.756 -21.25%

ALACT.PA Predictions History

StockInvest.us BE THE FIRST TO PREDICT

The excellent way of becoming a better trader


  • Easy to use
  • Enhance your skills
  • Predict as many as you like
  • Request predictions
  • Gather points
  • Learn to time your buy and sells

I wonder how good you are and if you can beat me?

Now it is your turn to become professional by doing what professionals do - Exercise

Best regards,

Jim - Co-founder of StockInvest.us [ See tutorial video ]

Click to get the best stock tips daily for free!

About Groupe Actiplay SA

Groupe Actiplay SA Acticor Biotech SAS operates as a clinical stage biotechnology company that develops drugs for the treatment of acute phase of thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets a specific platelet glycoprotein. It is also involved in two clinical programs in Phase II/III registration for the treatment of ischemic stroke; and two other Phase II trials addressing major cardiovascular emerge... ALACT.PA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT